OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
October 06, 2023
Tracy Nasarenko offers her final thoughts on DSCSA implementation guidelines at LogiPharma USA 2023.
Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.
October 05, 2023
GS1 US Executive provides insight on how pharma supply can speed up the process of complying with regulations.
In an interview at LogiPharma USA 2023 with Pharma Commerce Editor Nicholas Saraceno, Tracy Nasarenko, Sr. Director of Community Engagement for Pharmaceuticals, GS1 US highlights her “DSCSA—Final Checks to Have Before Deadlines.”
LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.
Panel discusses how digital transformation can best impact supply chains.
Boehringer Ingelheim’s unbranded adalimumab-adbm biosimilar will be available at an 81% discount to adalimumab (Humira).
October 04, 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
Exec joins the organization with decades of biopharma experience.
October 03, 2023
Statistics shows it up 1.5%, representing first annual growth since February 2022